https://economictimes.indiatimes.com/markets/stocks/news/mope-and-invascent-buy-70-in-symbiotec-for-100-m/articleshow/67140276.cms
Symbiotec: MOPE and InvAscent buy 70% in Symbiotec for $100 m - The Economic Times
PE fund Actis sells the stake in API maker, valuing company at $140 m.